FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:  8.216089|Direction: 1|PValue:1.64399e-02|FDR:0.298307441;FeatureName:number_of_lymphnodes_positive_by_he|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.270640|Direction: 1|PValue:1.03121e-02|FDR:0.358345931;FeatureName:synchronous_colon_cancer_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:149.000000|Direction:-1|PValue:1.13806e-02|FDR:0.417962502;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:  6.400260|Direction: 1|PValue:4.07569e-02|FDR:0.125893524;FeatureName:MSI_status_TCGAPaper_twogroup|Type:BIN|StatisticMethod:ranktest|GroupComparison:MSS/MSI|Statistics:904.000000|Direction: 1|PValue:2.35667e-02|FDR:0.098859724;FeatureName:MLH1_silencing|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:596.000000|Direction: 1|PValue:4.70335e-03|FDR:0.046697513;FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:710.000000|Direction: 1|PValue:1.33304e-03|FDR:0.007126611;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.494204|Direction:-1|PValue:1.02422e-05|FDR:0.000203381;FeatureName:nonsilent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.421686|Direction:-1|PValue:2.25017e-04|FDR:0.005212902;FeatureName:DNAH2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:704.000000|Direction: 1|PValue:1.44199e-02|FDR:0.200282744;FeatureName:RYR1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:720.000000|Direction: 1|PValue:2.49511e-02|FDR:0.252738071;FeatureName:CSMD3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:692.000000|Direction: 1|PValue:2.11972e-02|FDR:0.245534707;FeatureName:TTN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:602.000000|Direction:-1|PValue:1.08666e-02|FDR:0.198930219;FeatureName:MUC16_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:863.000000|Direction: 1|PValue:1.29849e-02|FDR:0.062238043;FeatureName:LRP2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:298.000000|Direction:-1|PValue:1.86806e-02|FDR:0.222536382;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.284705|Direction: 1|PValue:7.17811e-03|FDR:0.024335533;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.274936|Direction: 1|PValue:9.53056e-03|FDR:0.033118711;FeatureName:13q12.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.287133|Direction: 1|PValue:6.67968e-03|FDR:0.060992563;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.216621|Direction: 1|PValue:4.26452e-02|FDR:0.287103498;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.325543|Direction: 1|PValue:1.96835e-03|FDR:0.022800049;FeatureName:13q22.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.326778|Direction: 1|PValue:1.88739e-03|FDR:0.018739046;FeatureName:6p21.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.296304|Direction: 1|PValue:5.06188e-03|FDR:0.078177862;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.241405|Direction: 1|PValue:2.34620e-02|FDR:0.059294865;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.309322|Direction:-1|PValue:3.36259e-03|FDR:0.155799880;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.249795|Direction:-1|PValue:1.89191e-02|FDR:0.101144446;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.223443|Direction:-1|PValue:3.63810e-02|FDR:0.095414450;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.261931|Direction:-1|PValue:1.36936e-02|FDR:0.157807248